Tag: postmarket surveillance

How the FDA Monitors Drug Safety After Medication Approval

By Joe Barnett    On 2 Feb, 2026    Comments (0)

blog-post-image

The FDA doesn't stop monitoring drugs after approval. Using FAERS, Sentinel, AI tools, and REMS programs, it tracks side effects in millions of real-world patients to catch hidden risks and protect public health.

View More

Categories

Recent Post

recent-post-image ADHD Stimulants and MAOIs: What You Need to Know About Hypertensive Crisis Risks
recent-post-image Elimite (Permethrin 5% Cream): Uses, How to Apply, Side Effects, and FAQs
recent-post-image Valproic Acid and the Brain: Neurological Effects Explained
recent-post-image Fluticasone and Immunity: Does Long‑Term Use Affect Your Immune System?
recent-post-image How to Subscribe to FDA Drug Safety Alerts and Updates

Menu

© 2026. All rights reserved.